Pattern of Gene Expression and Immune Responses to Semenogelin 1 in Chronic Hematologic Malignancies

Journal of Immunotherapy

Volumn 26, Issue 6, 2003, Pages 461-467

  Zhang, Yana ^b   Wang, Zhiqing ^b   Liu, Haichao ^b   Giles, Francis J ^b   Lim, Seah H ^a  

^a Harrington Cancer Center   (United States)

^b NONE

Author keywords

Chronic leukemias; Semenogelin 1, cancer testis antigens

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MESSENGER RNA; PROTEIN SPAN XB; RECOMBINANT PROTEIN; SEMENOGELIN 1; SPERM PROTEIN 17; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; BLOOD; BLOOD DONOR; BONE MARROW; CELL LYSATE; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FETUS; GENE EXPRESSION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOGENICITY; LEUKEMIA CELL; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SEMINAL VESICLE; SPERM; TESTIS; TISSUE SPECIFICITY; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEMINAL VESICLE SECRETORY PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0242472891     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200311000-00001     Document Type: Article

References (22)

1. De Plaen E, Lurquin C, Brichard V, et al. Cloning of genes coding for antigens recognized by cytolytic T lymphocytes. In: Lefkovits I, ed. The Immunology Methods Manual. San Diego, CA: Academic Press, 1997; p 692.
2. Cox AL, Skipper J, Chen Y, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science. 1994;264:716-719.
3. Ling M, Wen YJ, Lim SH. Prevalence of antibodies against proteins derived from leukemia cells in patients with chronic myeloid leukemia. Blood. 1998;92:4764-4770.
4. Chen Y-T, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA. 1997;94:1914-1918.
5. Sahin U, Tureci O, Schmitt H, et al. Human neoplasms elicit multiple specific immune responses in autologous host. Proc Natl Acad Sci USA. 1995;92:11810-11813.
6. Lim SH, Austin S, Owen-Jones E, et al. Expression of testicular genes in haematological malignancies. Br J Cancer. 1998;81:1162-1164.
7. Lim SH, Wang Z, Chiriva-Internati M, et al. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood. 2001;97:1508-1510.
8. Wang Z, Zhang Y, Liu H, et al. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood. 2003;101:955-960.
9. Wu CJ, Yang XF, McLaughlin S, et al. Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest. 2000;106:705-714.
10. Chiriva-Internati M, Wang Z, Salati E, et al. Tumor vaccine of ovarian cancer targeting Sperm protein 17 (Sp17). Cancer. 2002;94:2447-2453.
11. Chiriva-Internati M, Wang Z, Xue Y, et al. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk. Eur J Immunol. 2001;31:2277-2283.
12. Chiriva-Internati M, Wang Z, Salati E, et al. Successful generation of Sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumor-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Scand J Immunol. 2002;56:429-433.
13. Chiriva-Internati M, Wang Z, Salati E, et al. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma. Blood. 2002;100:961-965.
14. Lim SH, Bumm K, Chiriva-Internati M, et al. MAGE-C1 (CT7) gene expression in multiple myeloma: relationship to Sperm protein 17. Eur J Haematol. 2001;67:332-334.
15. De Lamirande E, Yoshida K, Yoshiike TM, et al. Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process. J Androl. 2001;22:672-679.
16. Ulvsback M, Lazure C, Lilja H, et al. Gene structure of semenogelin I and II: the predominant proteins in human semen are encoded by two homologous genes on chromosome 20. J Biol Chem. 1992;267:18080-18084.
17. Asimakopoulos FA, White NJ, Nacheva E, et al. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 1994;84:3086-3094.
18. Rodrizues RG, Panizo-Santos A, Cashel JA, et al. Semenogelins are ectopically expressed in small cell lung carcinoma. Clin Cancer Res. 2001;7:854-860.
19. Sigalotti L, Coral S, Altomonte M, et al. Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer. 2002;86:979-982.
20. Evans RJ, Herr JC. Immunohistochemical localization of the MHS-5 antigen in principal cells of human seminal vesicle epithelium. Anat Rec. 1986;214:372-377.
21. Bjartell A, Malm J, Moller C, et al. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry. J Androl. 1996;17:17-26.
22. Krackhardt AM, Witzens M, Harig S, et al. Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood. 2002;100:2123-2131.